449 related articles for article (PubMed ID: 12907335)
21. Association of MALTectomy (appendectomy and tonsillectomy) and inflammatory bowel disease: a familial case-control study.
López Ramos D; Gabriel R; Cantero Perona J; Moreno Otero R; Fernández Bermejo M; Maté Jiménez J
Rev Esp Enferm Dig; 2001 May; 93(5):303-14. PubMed ID: 11488108
[TBL] [Abstract][Full Text] [Related]
22. Generational differences in the age at diagnosis with Ibd: genetic anticipation, bias, or temporal effects.
Faybush EM; Blanchard JF; Rawsthorne P; Bernstein CN
Am J Gastroenterol; 2002 Mar; 97(3):636-40. PubMed ID: 11922559
[TBL] [Abstract][Full Text] [Related]
23. [Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association].
von Tirpitz C; Steder-Neukamm U; Glas K; Sander S; Ring C; Klaus J; Reinshagen M
Z Gastroenterol; 2003 Dec; 41(12):1145-50. PubMed ID: 14661123
[TBL] [Abstract][Full Text] [Related]
24. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
25. Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study.
Munk EM; Pedersen L; Floyd A; Nørgård B; Rasmussen HH; Sørensen HT
Am J Gastroenterol; 2004 May; 99(5):884-8. PubMed ID: 15128355
[TBL] [Abstract][Full Text] [Related]
26. Risk of arterial thrombotic events in inflammatory bowel disease.
Ha C; Magowan S; Accortt NA; Chen J; Stone CD
Am J Gastroenterol; 2009 Jun; 104(6):1445-51. PubMed ID: 19491858
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease.
Vestergaard P
Minerva Med; 2004 Dec; 95(6):469-80. PubMed ID: 15785432
[TBL] [Abstract][Full Text] [Related]
28. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
29. Predictors of corticosteroid-dependent and corticosteroid-refractory inflammatory bowel disease: analysis of a Chinese cohort study.
Chow DK; Sung JJ; Tsoi KK; Wong VW; Wu JC; Leong RW; Chan FK
Aliment Pharmacol Ther; 2009 Apr; 29(8):843-54. PubMed ID: 19154567
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for abnormal liver function tests in patients with ileal pouch-anal anastomosis for underlying inflammatory bowel disease.
Navaneethan U; Remzi FH; Nutter B; Fazio VW; Shen B
Am J Gastroenterol; 2009 Oct; 104(10):2467-75. PubMed ID: 19550410
[TBL] [Abstract][Full Text] [Related]
31. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.
Bernstein CN; Blanchard JF; Rawsthorne P; Yu N
Am J Gastroenterol; 2001 Apr; 96(4):1116-22. PubMed ID: 11316157
[TBL] [Abstract][Full Text] [Related]
32. Repeat endoscopy affects patient management in pediatric inflammatory bowel disease.
Thakkar K; Lucia CJ; Ferry GD; McDuffie A; Watson K; Tsou M; Gilger MA
Am J Gastroenterol; 2009 Mar; 104(3):722-7. PubMed ID: 19209163
[TBL] [Abstract][Full Text] [Related]
33. Utilization of health care resources by individuals with inflammatory bowel disease in the United States: a profile of time since diagnosis.
Longobardi T; Jacobs P; Bernstein CN
Am J Gastroenterol; 2004 Apr; 99(4):650-5. PubMed ID: 15089897
[TBL] [Abstract][Full Text] [Related]
34. Fracture risk associated with systemic and topical corticosteroids.
Vestergaard P; Rejnmark L; Mosekilde L
J Intern Med; 2005 Apr; 257(4):374-84. PubMed ID: 15788008
[TBL] [Abstract][Full Text] [Related]
35. Risk factors of colorectal cancer in inflammatory bowel disease.
Bansal P; Sonnenberg A
Am J Gastroenterol; 1996 Jan; 91(1):44-8. PubMed ID: 8561142
[TBL] [Abstract][Full Text] [Related]
36. The population risk of fractures attributable to oral corticosteroids.
Donnan PT; Libby G; Boyter AC; Thompson P
Pharmacoepidemiol Drug Saf; 2005 Mar; 14(3):177-86. PubMed ID: 15672413
[TBL] [Abstract][Full Text] [Related]
37. Inhaled corticosteroids and the risk of fracture in chronic obstructive pulmonary disease.
Pujades-Rodríguez M; Smith CJ; Hubbard RB
QJM; 2007 Aug; 100(8):509-17. PubMed ID: 17609226
[TBL] [Abstract][Full Text] [Related]
38. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.
Vind I; Riis L; Jess T; Knudsen E; Pedersen N; Elkjaer M; Bak Andersen I; Wewer V; Nørregaard P; Moesgaard F; Bendtsen F; Munkholm P;
Am J Gastroenterol; 2006 Jun; 101(6):1274-82. PubMed ID: 16771949
[TBL] [Abstract][Full Text] [Related]
39. Stress coping, distress, and health perceptions in inflammatory bowel disease and community controls.
Graff LA; Walker JR; Clara I; Lix L; Miller N; Rogala L; Rawsthorne P; Bernstein CN
Am J Gastroenterol; 2009 Dec; 104(12):2959-69. PubMed ID: 19755973
[TBL] [Abstract][Full Text] [Related]
40. Are patients with inflammatory bowel disease receiving optimal care?
Reddy SI; Friedman S; Telford JJ; Strate L; Ookubo R; Banks PA
Am J Gastroenterol; 2005 Jun; 100(6):1357-61. PubMed ID: 15929770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]